Archives

  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugat...

    2026-01-12

    Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated: Mechanistic Insights, Evidence & Applications

    Executive Summary: The Affinity-Purified Goat Anti-Mouse IgG (H+L), Horseradish Peroxidase Conjugated antibody (SKU: K1221) is a polyclonal secondary antibody designed for broad detection of mouse IgG heavy and light chains, enabling sensitive immunodetection in Western blot, ELISA, and immunohistochemistry (IHC) workflows (APExBIO). This reagent is affinity-purified for enhanced specificity and is conjugated to horseradish peroxidase (HRP) to provide robust enzymatic signal amplification (Li et al., 2024). The antibody is validated for research use only, with a defined storage and handling protocol for optimal stability. Recent literature demonstrates the essential role of high-sensitivity secondary antibodies in elucidating complex disease mechanisms, including the regulation of the Hippo pathway in oncology (DOI:10.1038/s41419-024-06595-9). This article provides atomic, verifiable facts on the mechanism, benchmarks, and integration of the K1221 kit in immunological research.

    Biological Rationale

    Secondary antibodies are critical for the detection and quantification of primary antibodies in immunoassays. Mouse monoclonal and polyclonal antibodies are widely used as primary reagents in biomedical research, especially in oncology and immunology (Li et al., 2024). The Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated antibody specifically recognizes both heavy and light chains of mouse IgG, ensuring compatibility with a broad range of mouse-derived primary antibodies (APExBIO). Horseradish peroxidase conjugation enables enzymatic amplification of detection signals, which is essential for identifying low-abundance targets in complex biological samples. This amplification is particularly important for studying signaling pathways and post-translational modifications such as those involved in colorectal cancer progression and Hippo pathway regulation (DOI:10.1038/s41419-024-06595-9).

    Mechanism of Action of Affinity-Purified Goat Anti-Mouse IgG (H+L), Horseradish Peroxidase Conjugated

    The antibody is produced by immunizing goats with pooled mouse IgG, followed by affinity purification using antigen-coupled agarose beads to remove non-specific immunoglobulins. The purified polyclonal antibody is then conjugated to horseradish peroxidase (HRP), an enzyme that catalyzes the oxidation of substrates such as tetramethylbenzidine (TMB) or diaminobenzidine (DAB) in the presence of hydrogen peroxide, resulting in a colorimetric or chemiluminescent signal (APExBIO). This secondary antibody binds specifically to mouse IgG (both H and L chains), enabling detection of mouse primary antibodies in a variety of immunoassay formats. The presence of 1% BSA and 50% glycerol in PBS (pH 7.4) stabilizes the antibody, while 0.01% Proclin 300 serves as a preservative. The product should be stored at 4°C for up to 2 weeks or at -20°C for up to 12 months, avoiding freeze-thaw cycles to maintain antibody integrity.

    Evidence & Benchmarks

    • Sensitivity and specificity of the Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated antibody have been validated in Western blot, ELISA, and IHC applications using mouse IgG as the primary antibody (APExBIO).
    • Peer-reviewed studies demonstrate the necessity of high-sensitivity secondary antibodies for detecting low-abundance proteins, such as angiomotins and YAP pathway components in colorectal cancer research (Li et al., 2024, Figure 2).
    • The HRP-conjugated format allows for sub-nanogram detection limits in optimized ELISA workflows, with signal-to-noise ratios exceeding 100:1 under standard conditions (1 mg/mL, PBS pH 7.4, room temperature) (Product Documentation).
    • Stability testing shows functional retention for up to 12 months at -20°C, provided freeze-thaw cycles are minimized (APExBIO, Product Sheet).
    • Compared to unconjugated or less purified secondary antibodies, affinity-purified HRP-conjugates provide lower background and higher reproducibility in translational research settings (Internal Article: Protein G Beads).

    Applications, Limits & Misconceptions

    This antibody is primarily intended for research applications including:

    • Western blot detection of mouse IgG-bound proteins
    • ELISA assays for quantitative or qualitative detection
    • Immunohistochemistry (IHC) and immunofluorescence on fixed tissues
    • Signal amplification in low-abundance target studies

    While the antibody offers broad compatibility and robust amplification, its use is limited to research settings. It is not validated for clinical diagnostics or therapeutic applications. The antibody will not recognize non-mouse IgG or immunoglobulins from other species. Overuse or failure to aliquot may result in loss of activity due to repeated freeze-thaw cycles. For a strategic overview of integrating advanced secondary antibodies into translational workflows, see Empowering Translational Research: Mechanistic and Strategic Integration, which is complemented here by specific, product-level benchmarks and mechanistic details.

    Common Pitfalls or Misconceptions

    • The antibody is not suitable for detection of non-mouse primary antibodies.
    • It is not intended for use in diagnostic or therapeutic procedures.
    • Repeated freeze-thaw cycles will degrade antibody activity; always aliquot for storage.
    • High background may result from insufficient washing or suboptimal blocking; always use the recommended 1% BSA in PBS.
    • Cross-reactivity with endogenous immunoglobulins can occur in samples containing mouse serum; use species-specific blocking if necessary.

    Workflow Integration & Parameters

    Optimal performance is achieved by diluting the antibody according to assay requirements (typically 1:5,000–1:20,000 for Western blot; 1:1,000–1:10,000 for ELISA). The antibody is supplied at 1 mg/mL in PBS (pH 7.4) with 1% BSA, 50% glycerol, and 0.01% Proclin 300. Store at 4°C for up to 2 weeks; aliquot and freeze at -20°C for up to 12 months. Avoid repeated freeze-thaw cycles. For additional workflow optimization strategies, see Translational Immunodetection Redefined, which this article extends by providing more granular, atomic claims and updated evidence from recent oncology research.

    Conclusion & Outlook

    The Affinity-Purified Goat Anti-Mouse IgG (H+L), Horseradish Peroxidase Conjugated antibody from APExBIO remains a cornerstone reagent for sensitive and specific immunodetection of mouse IgG across research platforms. Its validated performance, low background, and robust amplification make it an essential tool for translational research, particularly in the study of signaling pathways and disease mechanisms. Future developments may include multiplexed detection and expanded host species compatibility, but for now, the K1221 kit sets a benchmark for reproducibility and sensitivity in immunological assays. For a clinical-translational perspective, see From Mechanism to Medicine: Strategic Immunodetection for Translational Impact, which this article updates with current evidence and protocol-level details.